Niagen Bioscience Financials

Values in thousands	2026-06-30	2026-03-31	2025-12-31	2025-09-30
Revenue	$29,785	$31,474	$33,839	$33,986
Gross Profit	19,314	19,976	21,704	21,928
EBITDA	1,170	7,026	5,288	4,995
EBIT	700	6,735	4,424	4,800
Net Income	963	6,318	4,131	4,578
Net Change In Cash	29,785	31,474	33,839	33,986
Free Cash Flow	2,683	-1,255	578	3,668
Cash	66,740	66,549	64,788	64,138
Basic Shares	82,504	84,566	84,444	86,619

Values in thousands	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Revenue	$129,423	$99,597	$83,570	$72,050
Gross Profit	83,189	61,586	50,780	42,797
EBITDA	19,642	10,339	-3,233	-14,656
EBIT	18,192	8,855	-4,938	-16,540
Net Income	17,382	8,550	-4,938	-16,540
Net Change In Cash	129,423	99,597	83,570	72,050
Free Cash Flow	13,145	11,946	6,969	-15,432
Cash	64,788	44,508	27,173	20,289
Basic Shares	85,436	79,724	74,985	69,729